To improve the quality of life and prevent blood cancer in RUNX1-FPD patients.
RUNX1 Foundation dba RUNX1 Research Program centers its funding on RUNX1 familial platelet disorder and the prevention of blood cancer in people with RUNX1-FPD. Recent grants show a research program built around disease mechanisms, interception, and translational work rather than direct service funding. The largest recent award in the data is $328,750 to the University of Pennsylvania for independent grants, alongside a $250,000 grant to American Cancer Society for grants. The foundation also backed Boston Children's Hospital twice at $250,000 in 2024 and 2023, including one project noted as research partnered with NIH. Other awards support investigator teams, early-career researchers, and partner programs connected to inherited hematologic malignancy predisposition. That mix matches the foundation’s stated goal of improving quality of life and preventing blood cancer in RUNX1-FPD patients. The grant list also includes work tied to clinical and translational research, patient registries, biobanking resources, and collaborative research partnerships, indicating a field-building approach that supports both individual projects and shared infrastructure for RUNX1-focused science.
Inherited hematologic malignancy predisposition is a central theme in the portfolio. The foundation gave $30,000 to Cleveland Clinic Foundation for ECI Clinical Researcher, and $30,000 to St Jude Children's Research for Early Career Investigator ALSF, both aligned with early-stage research careers. It also supported a $46,875 Familial RUNX1 Research ALSF award to University of Mass Medical School, showing continued backing for family-based RUNX1 studies. In translational research, the foundation awarded $235,000 to University of Pennsylvania through RRP Independent Grant funding and $125,000 to Leland Stanford Junior University for research partnered with MFCR. Collaborative prevention-oriented work appears in a $250,000 grant to American Cancer Society and a $150,000 award to Oregon Health & Science Univ Founda for research pship with ALSFEP Evans. These grants point to a portfolio that combines basic disease modeling, prevention, and clinical research.
Typical awards cluster around mid-five figures and low-six figures, with a p25 of $30,000, a median of $45,938, and a p75 of $125,000. The upper end includes larger programmatic grants such as $250,000 awards and a $328,750 independent grant. The portfolio also shows repeated support to the same institutions across multiple years, including University of Pennsylvania, Boston Children's Hospital, and Children's Hospital of Philadelphia, which suggests ongoing relationships rather than one-off awards. The foundation operates through its own grant programs and partnerships with organizations such as Alex's Lemonade Stand Foundation, NIH, MFCR, and the Edward P. Evans Foundation. Some opportunities accept unsolicited applications, including the LEAP Grant and ECI program.
$3.2M
$320K
$2.4M
$2.4M
Most grants fall between $30K and $125K, with a median of $46K.
25th Percentile
$30K
Median
$46K
75th Percentile
$125K
About 8% of grants go to recipients in MA.
Katrin Ericson
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
The grant map is national, with all recent grants in the United States. Massachusetts appears most often as the recipient state, while California accounts for 8% of grants. Recipient cities recur in Boston, Philadelphia, Worcester, and Seattle, with additional awards in Atlanta, Houston, and Memphis. The recent list also includes grants to Bronx and New York City institutions, indicating that the program funds across major research hubs rather than concentrating in one metro area.
The portfolio centers on RUNX1 familial platelet disorder, inherited hematologic malignancy predisposition, blood cancer prevention and interception, clinical and translational research, patient registries and data hubs, and biobanking. Recent grants include work at University of Pennsylvania, Boston Children's Hospital, and American Cancer Society.
Typical awards are in the mid-five-figure to low-six-figure range. The provided distribution shows a p25 of $30,000, a median of $45,938, and a p75 of $125,000.
Yes. The active program list includes an Early Career Investigator grant program, and recent grants include $30,000 awards to Cleveland Clinic Foundation for ECI Clinical Researcher and to St Jude Children's Research for Early Career Investigator ALSF.
No. The recent grants are entirely in the United States, with Massachusetts the most frequent recipient state and California receiving 8% of grants. Recent recipient cities include Boston, Philadelphia, Worcester, Seattle, Atlanta, Houston, and Memphis.
Yes. The grant list includes partnerships with NIH, ALSF, MFCR, and the Edward P. Evans Foundation. Examples include a $250,000 Boston Children's Hospital grant noted as research partnered with NIH and a $150,000 Oregon Health & Science Univ Founda grant tied to ALSFEP Evans.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| University of Pennsylvania | Philadelphia, PA | $328,750 | 2025 | RUNX1 Foundation - Independent Grants |
| American Cancer Society | Atlanta, GA | $250,000 | 2025 | Grants |
| Childrens Hospital of Philadelphia | Philadelphia, PA | $148,750 | 2025 | Independent RRP Grant |
| University of Texas MD Anderson | Houston, TX | $109,058 | 2025 | RUNX1 Foundation - Independent Grants |
| University of Mass Medical School | Worcester, MA | $46,875 | 2025 | Familial RUNX1 Research ALSF |
| Cleveland Clinic Foundation | Cleveland, OH | $30,000 | 2025 | ECI Clinical Researcher |
| Albert Einstein College of Medicine | Bronx, NY | $30,000 | 2025 | Early Career Investigator ALSF |
| Regents of University of CA Med Sch | San Francisco, CA | $30,000 | 2025 | Early Career Investigator ALSF |
| St Jude Childrens Research | Memphis, TN | $30,000 | 2025 | Early Career Investigator ALSF |
| University of Washington Medicine | Seattle, WA | $30,000 | 2025 | Early Career Investigator ALSF |
| Dana Farber Cancer Institute | Boston, MA | $15,000 | 2025 | Early Career Investigator ALSF |
| Boston Childrens Hospital | Boston, MA | $7,384 | 2025 | Research |
| Boston Childrens Hospital | Boston, MA | $250,000 | 2024 | RiSE Grant Program |
| University of Pennsylvania | Philadelphia, PA | $235,000 | 2024 | RRP Independent Grant |
| Edward P Evans Foundation | Andover, MA | $50,000 | 2024 | Research pship with EP Evans |
| Childrens Hospital of Philadelphia | Philadelphia, PA | $46,875 | 2024 | Independent RRP Grant |
| Dana Farber Cancer Institute | Boston, MA | $45,000 | 2024 | Research partnered with ALSF |
| University of Mass Medical School | Worcester, MA | $38,443 | 2024 | Research in partnership with MFCR |
| University of Washington Medicine | Seattle, WA | $30,000 | 2024 | Research in partnership with ALSF |
| St Jude Childrens Research | Memphis, TN | $30,000 | 2024 | Research in partnership with ALSF |
| Albert Einstein College of Medicine | Bronx, NY | $30,000 | 2024 | Research partnered with ALSF |
| Memorial Sloan Kettering Cancer Ctr | New York, NY | $30,000 | 2024 | Research in partnership with ALSF |
| Regents of University of CA Med Sch | San Francisco, CA | $30,000 | 2024 | Research in partnership with ALSF |
| BOSTON CHILDRENS HOSPITAL | Boston, MA | $250,000 | 2023 | Research partnered with NIH |
| UNIVERSITY OF PENNSYLVANIA | Philadelphia, PA | $200,000 | 2023 | Independent Research |
| OREGON HEALTH & SCIENCE UNIV FOUNDA | Portland, OR | $150,000 | 2023 | Research pship with ALSFEP Evans |
| LELAND STANFORD JUNIOR UNIVERSITY | Stanford, CA | $125,000 | 2023 | Research partnered with MFCR |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | Worcester, MA | $125,000 | 2023 | Research partnered with MFCR |
| UNIVERSITY OF CHICAGO | Chicago, IL | $125,000 | 2023 | Research in partnership with MFCR |
| Vanderbilt University School of Med | Nashville, TN | $100,000 | 2023 | Research pship with EP Evans |
| Boston Childrens Hospital | Boston, MA | $80,000 | 2023 | Research in partnership with ALSF |
| CHILDRENS HOSPITAL OF PHILADELPHIA | Philadelphia, PA | $50,000 | 2023 | Research partnered with ALSF |
| DANA FARBER CANCER INSTITUTE | Boston, MA | $45,000 | 2023 | Research partnered with ALSF |
| Albert Einstein College of Medicine | Bronx, NY | $30,000 | 2023 | Research partnered with ALSF |
| Univ of Washington School of Medici | Seattle, WA | $30,000 | 2023 | Research partnered with ALSF |
| MEMORIAL SLOAN KETTERING CANCER CTR | New York, NY | $30,000 | 2023 | Research in partnership with ALSF |
University of Pennsylvania
$328,750RUNX1 Foundation - Independent Grants
American Cancer Society
$250,000Grants
Childrens Hospital of Philadelphia
$148,750Independent RRP Grant
University of Texas MD Anderson
$109,058RUNX1 Foundation - Independent Grants
University of Mass Medical School
$46,875Familial RUNX1 Research ALSF
Cleveland Clinic Foundation
$30,000ECI Clinical Researcher
Albert Einstein College of Medicine
$30,000Early Career Investigator ALSF
Regents of University of CA Med Sch
$30,000Early Career Investigator ALSF
St Jude Childrens Research
$30,000Early Career Investigator ALSF
University of Washington Medicine
$30,000Early Career Investigator ALSF
Dana Farber Cancer Institute
$15,000Early Career Investigator ALSF
Boston Childrens Hospital
$7,384Research
Boston Childrens Hospital
$250,000RiSE Grant Program
University of Pennsylvania
$235,000RRP Independent Grant
Edward P Evans Foundation
$50,000Research pship with EP Evans
Childrens Hospital of Philadelphia
$46,875Independent RRP Grant
Dana Farber Cancer Institute
$45,000Research partnered with ALSF
University of Mass Medical School
$38,443Research in partnership with MFCR
University of Washington Medicine
$30,000Research in partnership with ALSF
St Jude Childrens Research
$30,000Research in partnership with ALSF
Albert Einstein College of Medicine
$30,000Research partnered with ALSF
Memorial Sloan Kettering Cancer Ctr
$30,000Research in partnership with ALSF
Regents of University of CA Med Sch
$30,000Research in partnership with ALSF
BOSTON CHILDRENS HOSPITAL
$250,000Research partnered with NIH
UNIVERSITY OF PENNSYLVANIA
$200,000Independent Research
OREGON HEALTH & SCIENCE UNIV FOUNDA
$150,000Research pship with ALSFEP Evans
LELAND STANFORD JUNIOR UNIVERSITY
$125,000Research partnered with MFCR
UNIVERSITY OF MASSACHUSETTS MEDICAL
$125,000Research partnered with MFCR
UNIVERSITY OF CHICAGO
$125,000Research in partnership with MFCR
Vanderbilt University School of Med
$100,000Research pship with EP Evans
Boston Childrens Hospital
$80,000Research in partnership with ALSF
CHILDRENS HOSPITAL OF PHILADELPHIA
$50,000Research partnered with ALSF
DANA FARBER CANCER INSTITUTE
$45,000Research partnered with ALSF
Albert Einstein College of Medicine
$30,000Research partnered with ALSF
Univ of Washington School of Medici
$30,000Research partnered with ALSF
MEMORIAL SLOAN KETTERING CANCER CTR
$30,000Research in partnership with ALSF
Current and upcoming funding from Runx1 Foundation Dba Runx1 Research Program that your nonprofit may be able to apply for.
Who can apply: Supports early-career scientists focused on inherited hematologic malignancy predisposition disorders, particularly RUNX1-FPD.
Deadline: Application Deadline: December 2026
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.
